Peter L. Saltonstall
Director/Board Member chez Medical Device Innovation Consortium
Profil
Peter L.
Saltonstall is currently a Director at Trio Health Advisory Group, Inc. and a Director at Medical Device Innovation Consortium.
He was previously the President, Chief Executive Officer & Director at The National Organization for Rare Disorders, Inc.
Postes actifs de Peter L. Saltonstall
Sociétés | Poste | Début |
---|---|---|
Medical Device Innovation Consortium
Medical Device Innovation Consortium Miscellaneous Commercial ServicesCommercial Services Medical Device Innovation Consortium (MDIC) is a collective endeavor focused on realizing the potential of transformative innovation in the medical device industry. The private company is based in St. Louis Park, MN. The company encourages med device companies to adopt advanced technologies such as AI, ML, and IoT to develop supply resiliency, production agility, innovation rigor, and secure medical product supply. MDIC's CFQ program is a dynamic collaborative exchange and engagement of diverse experiences and professional insights in advancing innovation to the forefront of patient safety and accessibility. The company was founded by William A. Hawkins. Andrew Fish has been the CEO of the company since 2022. | Director/Board Member | 01/02/2016 |
Trio Health Advisory Group, Inc.
Trio Health Advisory Group, Inc. Packaged SoftwareTechnology Services Trio Health Advisory Group, Inc. offers a CareLogic, a proprietary system to collect and share information from all stakeholders. The firm?s services include multi-disease platform, data analytics, scientific steering committee and client deliverables. The company was founded by Yoori Lee and Brent Clough in 2013 and is headquartered in La Jolla, CA. | Director/Board Member | - |
Anciens postes connus de Peter L. Saltonstall
Sociétés | Poste | Fin |
---|---|---|
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Chief Executive Officer | 01/05/2024 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Trio Health Advisory Group, Inc.
Trio Health Advisory Group, Inc. Packaged SoftwareTechnology Services Trio Health Advisory Group, Inc. offers a CareLogic, a proprietary system to collect and share information from all stakeholders. The firm?s services include multi-disease platform, data analytics, scientific steering committee and client deliverables. The company was founded by Yoori Lee and Brent Clough in 2013 and is headquartered in La Jolla, CA. | Technology Services |
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Health Services |
Medical Device Innovation Consortium
Medical Device Innovation Consortium Miscellaneous Commercial ServicesCommercial Services Medical Device Innovation Consortium (MDIC) is a collective endeavor focused on realizing the potential of transformative innovation in the medical device industry. The private company is based in St. Louis Park, MN. The company encourages med device companies to adopt advanced technologies such as AI, ML, and IoT to develop supply resiliency, production agility, innovation rigor, and secure medical product supply. MDIC's CFQ program is a dynamic collaborative exchange and engagement of diverse experiences and professional insights in advancing innovation to the forefront of patient safety and accessibility. The company was founded by William A. Hawkins. Andrew Fish has been the CEO of the company since 2022. | Commercial Services |